AMNEAL PHARMACEUTICALS INC CLASS A (AMRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AMRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMRX | Board Member; Director | 53 | ["Managing Director of Tarsadia Investments", "Led financial and strategic advisory efforts at Lazard", "Experience in M&A", "Knowledge of the Company\u2019s business and operations", "Deep experience in finance, corporate development, and healthcare investing"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SPB | Independent Director; Managing Director of Tarsadia Investments | 54 | ["Business Operations","Consumer Products","Corporate Governance","Corporate Strategy & Business Development","Ethics/Corporate Social Responsibility","Executive Leadership & Management","International Business Experience","Marketing/Sales or Brand Management","Mergers & Acquisitions","Public Company Executive Experience","Managing Director of Tarsadia Investments since 2012","Managing Director at Lazard from 2008 to 2012","Advisory roles at Lazard from 1999 to 2008","Analyst at Donaldson, Lufkin & Jenrette from 1994 to 1997","B.A. from Claremont McKenna College","B.S. from Harvey Mudd College","MSc from the London School of Economics","MBA from the University of Chicago"] | ["C","Audit Committee (Chair)","Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Gautam Patel has served on our Board of Directors since the Combination. Mr. Patel has been a Managing Director of Tarsadia Investments, a private investment firm based in Newport Beach, California, since 2012. In that role, he has led a team of investment professionals to identify, evaluate and execute principal control over equity investments across sectors including life sciences, financial services and technology. Prior to joining Tarsadia, Mr. Patel served as a Managing Director at Lazard from 2008 to 2012, where he led financial and strategic advisory efforts in sectors including transportation and logistics, private equity, and healthcare. Prior to that, Mr. Patel served in a variety of advisory roles at Lazard from 1999 to 2008, including multiple restructuring, bankruptcy and corporate reorganization assignments in 2001 and 2008. From 1994 to 1997, Mr. Patel was an Analyst at Donaldson, Lufkin & Jenrette, where he worked on M&A as well as high-yield and equity financings. Mr. Patel is currently a Board Member of Spectrum Brands and several private companies such as Kashiv Biosciences, Asana Biosciences and Prolong Pharmaceuticals. Mr. Patel also serves on the board of Casita Maria Center for Arts & Education, a New York-based non-profit organization that aims to empower children through arts-based education. Mr. Patel received a Bachelor of Arts degree from Claremont McKenna College, a Bachelor of Science degree from Harvey Mudd College, an MSc from the London School of Economics and an M.B.A. from the University of Chicago. Mr. Patel brings an extensive knowledge of the Company's business and operations combined with deep experience in finance, corporate development and healthcare investing to the Board. Skills and Qualifications: Corporate Development, Business Development, M&A Finance and Accounting Investment, Venture Capital